Morgan Stanley expects Dr. Agarwal's revenue and Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to ...

Morgan Stanley placed a target price of Rs 502 on Dr. Agarwal's Health Care stock, implying an upside potential of 17% to the previous close.

If any of the displayed information needs updating, please click here. For concerns or queries regarding the information, feel free to email us. Medindia Constantly updates the database. However ...

An anchor lock-in refers to an investor being "locked" into a particular stock or investment due to a psychological or ...

Dr Agarwal's Health Care IPO comprised a fresh issue of up to ₹300 crore alongside an Offer For Sale (OFS) of up to 6.78 crore equity shares valued at ₹2,727.26 crore by promoters and other ...

Commenting on the financial performance, Dr Agarwal's Health Care Ltd CEO Dr Adil Agarwal said, "We have delivered a robust growth of 29.5 per cent in revenue and 26.3 per cent in EBITDA. We have ...